The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia.
作者信息
Ding Zhi-Chun
机构信息
Cancer Immunology, Immunotherapy and Tolerance Program, Georgia Cancer Center, Augusta University, Augusta, GA, USA.
出版信息
Ann Transl Med. 2018 Jun;6(11):235. doi: 10.21037/atm.2018.05.35.
Abstract
摘要
相似文献
1
The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia.嵌合抗原受体T细胞在复发B细胞急性淋巴细胞白血病中的前景与挑战
Ann Transl Med. 2018 Jun;6(11):235. doi: 10.21037/atm.2018.05.35.
2
A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia.复发或难治性急性淋巴细胞白血病的CD19靶向免疫疗法综述
J Oncol Pharm Pract. 2018 Sep;24(6):453-467. doi: 10.1177/1078155217713363. Epub 2017 Jun 5.
3
How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia.如何训练你的T细胞：基因工程嵌合抗原受体T细胞与双特异性T细胞衔接器在B细胞急性淋巴细胞白血病中靶向CD19的比较
Expert Opin Biol Ther. 2015 Jun;15(6):761-6. doi: 10.1517/14712598.2015.1009888. Epub 2015 Feb 2.
4
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.嵌合抗原受体T细胞疗法治疗急性淋巴细胞白血病：改变复发难治性疾病的治疗方式
Curr Hematol Malig Rep. 2018 Oct;13(5):396-406. doi: 10.1007/s11899-018-0470-x.
5
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.半相合CD19嵌合抗原受体T细胞与干细胞共同输注在难治性急性淋巴细胞白血病中实现了完全供者植入。
J Hematol Oncol. 2016 Nov 25;9(1):131. doi: 10.1186/s13045-016-0357-z.
6
Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.抗 CD19 嵌合抗原受体 T 细胞治疗复发或难治性 E2A-PBX1 阳性急性淋巴细胞白血病：三例报告。
Leuk Lymphoma. 2019 Jun;60(6):1454-1461. doi: 10.1080/10428194.2018.1533127. Epub 2019 Feb 4.
7
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.新型第 1928zT2 CAR T 细胞可诱导急性淋巴细胞白血病髓外复发缓解。
J Hematol Oncol. 2018 Feb 20;11(1):25. doi: 10.1186/s13045-018-0572-x.
8
[Efficacy of CD19 Chimeric Antigen Receptors T Cells in the Treatment of Relapsed Patients with B Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation].CD19嵌合抗原受体T细胞治疗异基因造血干细胞移植后复发的B细胞急性淋巴细胞白血病患者的疗效
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Aug;27(4):1040-1045. doi: 10.19746/j.cnki.issn.1009-2137.2019.04.008.
9
Chimeric antigen receptor T cells for acute lymphoblastic leukemia.嵌合抗原受体 T 细胞治疗急性淋巴细胞白血病。
Am J Hematol. 2019 May;94(S1):S24-S27. doi: 10.1002/ajh.25442. Epub 2019 Mar 22.
10
Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies.嵌合抗原受体 T 细胞（CAR-T）治疗 T 细胞恶性肿瘤。
Best Pract Res Clin Haematol. 2019 Dec;32(4):101097. doi: 10.1016/j.beha.2019.101097. Epub 2019 Oct 18.
引用本文的文献
1
Case Report: CD19 CAR-T cells derived from recipient of umbilical cord blood transplantation effectively treated relapsed acute lymphoblastic leukemia after UCBT.病例报告：来自脐带血移植受者的CD19嵌合抗原受体T细胞有效治疗了脐带血移植后的复发性急性淋巴细胞白血病。
Front Immunol. 2025 May 19;16:1586349. doi: 10.3389/fimmu.2025.1586349. eCollection 2025.
2
Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia.白血病中RAS信号通路靶向治疗的进展与挑战
Mol Cancer Ther. 2025 Jan 2;24(1):33-46. doi: 10.1158/1535-7163.MCT-24-0504.
3
Effects of Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia.突变对白血病发生的影响及急性淋巴细胞白血病患儿的靶向治疗
Front Cell Dev Biol. 2022 Feb 8;10:712484. doi: 10.3389/fcell.2022.712484. eCollection 2022.
4
Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report.嵌合抗原受体修饰的T细胞疗法治疗骨髓和皮肤复发的费城染色体样急性淋巴细胞白血病：一例报告
Medicine (Baltimore). 2020 May;99(18):e18639. doi: 10.1097/MD.0000000000018639.
5
Ras pathway mutation feature in the same individuals at diagnosis and relapse of childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病诊断和复发时同一患者的Ras通路突变特征
Transl Pediatr. 2020 Feb;9(1):4-12. doi: 10.21037/tp.2020.01.07.
本文引用的文献
1
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病中CD19嵌合抗原受体疗法的长期随访
N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919.
2
Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors.免疫检查点抑制剂药物研发范式分析。
Clin Cancer Res. 2018 Apr 15;24(8):1785-1794. doi: 10.1158/1078-0432.CCR-17-1970. Epub 2017 Dec 6.
3
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.用于血液系统恶性肿瘤的靶向CD19嵌合抗原受体T细胞疗法：解读迄今为止的临床结果
Blood. 2016 Jun 30;127(26):3312-20. doi: 10.1182/blood-2016-02-629063. Epub 2016 May 20.
4
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.用于治疗儿童和青年急性淋巴细胞白血病的表达CD19嵌合抗原受体的T细胞：一项1期剂量递增试验
Lancet. 2015 Feb 7;385(9967):517-528. doi: 10.1016/S0140-6736(14)61403-3. Epub 2014 Oct 13.
5
Chimeric antigen receptor T cells for sustained remissions in leukemia.用于白血病持续缓解的嵌合抗原受体T细胞。
N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa1407222.
6
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.19-28z嵌合抗原受体T细胞疗法治疗B细胞急性淋巴细胞白血病的疗效及毒性管理
Sci Transl Med. 2014 Feb 19;6(224):224ra25. doi: 10.1126/scitranslmed.3008226.
7
Gene-engineered T cells for cancer therapy.基因工程化 T 细胞用于癌症治疗。
Nat Rev Cancer. 2013 Aug;13(8):525-41. doi: 10.1038/nrc3565.
8
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.嵌合抗原受体修饰的 T 细胞治疗急性淋巴细胞白血病。
N Engl J Med. 2013 Apr 18;368(16):1509-1518. doi: 10.1056/NEJMoa1215134. Epub 2013 Mar 25.
9
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.CD19 靶向 T 细胞可迅速诱导化疗耐药的成人急性淋巴细胞白血病患者达到分子缓解。
Sci Transl Med. 2013 Mar 20;5(177):177ra38. doi: 10.1126/scitranslmed.3005930.
10
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.自体 CD19 靶向 T 细胞过继转移治疗复发或化疗耐药 B 细胞白血病患者的安全性和持久性。
Blood. 2011 Nov 3;118(18):4817-28. doi: 10.1182/blood-2011-04-348540. Epub 2011 Aug 17.
Zotero 插件